Cite
Repurposing doxycycline for synucleinopathies: remodelling of α-synuclein oligomers towards non-toxic parallel beta-sheet structured species
MLA
Claudio O. Fernández, et al. Repurposing Doxycycline for Synucleinopathies: Remodelling of α-Synuclein Oligomers towards Non-Toxic Parallel Beta-Sheet Structured Species. Feb. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f3e884d3e43ac895d917ceaff04f21bc&authtype=sso&custid=ns315887.
APA
Claudio O. Fernández, Rosangela Itri, Julia E. Sepulveda-Diaz, Sergio B. Socías, Rosana Chehín, Rita Raisman-Vozari, Florencia González-Lizárraga, Leandro R.S. Barbosa, Dulce Papy-Garcia, Clarisa M. Torres-Bugeau, César Ávila, Elaine Del-Bel, & Andres Binolfi. (2017). Repurposing doxycycline for synucleinopathies: remodelling of α-synuclein oligomers towards non-toxic parallel beta-sheet structured species.
Chicago
Claudio O. Fernández, Rosangela Itri, Julia E. Sepulveda-Diaz, Sergio B. Socías, Rosana Chehín, Rita Raisman-Vozari, Florencia González-Lizárraga, et al. 2017. “Repurposing Doxycycline for Synucleinopathies: Remodelling of α-Synuclein Oligomers towards Non-Toxic Parallel Beta-Sheet Structured Species,” February. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f3e884d3e43ac895d917ceaff04f21bc&authtype=sso&custid=ns315887.